ARCHIVES

Two New Modalities Promising For Relapsed/Refractory NHL

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Interview: “People don’t understand Clinical Trials.

September 5, 1997

In Brief: Bruce Chabner, DC director, To Leave NCI Next Spring For Position At Mass General

October 28, 1994

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

Latest State Cancer Statistics Released.

January 14, 2005

House Committee Investigates FDA Commissioner; False and Misleading Testimony Alleged.

April 6, 2007

GSK Vaccine Prevents Lesions Associated With HPV

July 28, 2006